google-site-verification: googlec7193c3de77668c9.html

Study tracks early adoption of liver histotripsy treatment

[
It has been nearly three years since the U.S. Food and Drug Administration (FDA) cleared the HistoSonics Edison histotripsy system to treat primary and metastatic liver tumors. To examine how the technology’s adoption and use have progressed, a research team at the University of Virginia, led by Allan Tsung, M.D., professor and chair of the Department of Surgery, sought to provide an early national snapshot of its use for this indication.


Source link

Advertisements

See also  Louisville found PFAS in drinking water: Trump administration wouldn't require any action

Check Also

Implantable cardioverter-defibrillators may benefit certain younger patients with mild–moderate heart dysfunction

[ Credit: Unsplash/CC0 Public Domain A more than a decade-long medical trial has opened the …

Physical exams alone may not reliably diagnose pneumonia in children, national study finds

[ Credit: Unsplash/CC0 Public Domain When a child has symptoms that could be pneumonia, doctors …

Studies reveal how instability may shape infant attention, brain activity and emotional regulation

[ Credit: Unsplash/CC0 Public Domain A baby’s brain is always listening, watching and learning—even when …

Leave a Reply

Available for Amazon Prime